To Compare: The coagulation process and the impact of coagulation modifier include anticoagulants, antiplatelet, thrombolytic, and antifibrinolytics. Concept introduction: Coagulation is otherwise called clotting. In this clotting process, the blood changes to gel from liquid. The forming of blood clot results in hemostasis. Generally, the clotting of blood occurs when the blood vessels are damaged. The protein is the coagulation process that is numbered by the Roman numerals from I- XIII. Some of the coagulation factors are II, VII, IX, and X, where all are produced in the liver except VIII.

Question

Want to see more full solutions like this?

Answer 1

Question

Chapter 26, Problem 1O

Summary Introduction

To Compare:

The coagulation process and the impact of coagulation modifier include anticoagulants, antiplatelet, thrombolytic, and antifibrinolytics.

Concept introduction:

Coagulation is otherwise called clotting. In this clotting process, the blood changes to gel from liquid. The forming of blood clot results in hemostasis. Generally, the clotting of blood occurs when the blood vessels are damaged. The protein is the coagulation process that is numbered by the Roman numerals from I- XIII. Some of the coagulation factors are II, VII, IX, and X, where all are produced in the liver except VIII.

Expert Solution & Answer

Explanation of Solution

Impact of coagulation modifier:

The coagulation modifier is the drug that takes action on the blood coagulation pathway to prevent or develop the formation of a clot. The coagulation modifiers are anticoagulants, antiplatelet drug, and thrombolytic drug.

Anticoagulants:

The anticoagulants prevent the formation of clotting factors and also avoid the formation of clots. The action of anticoagulant varying from one drug to another drug and the anticoagulant therapy are used for treating thrombosis.

Antiplatelet:

The antiplatelet blocks the platelet plugs from forming and preventing platelet aggregations. This process can be helpful in avoiding heart attack and strokes. Some of the antiplatelets include clopidogrel, dipyridamole, and ticlopidine.

Thrombolytic drug:

The important difference between thrombolytic and anticoagulant is to prevent the formation of blood clots. The thrombolytic drugs break the clots that are already present in the vessels. The thrombolytic is used as the injection to bust the clots by an intravenous line.

Antifibrinolytics drugs:

The hemostatic drug is otherwise called the antifibrinolytics drug that possesses the opposite effect when compared to the other class of drugs. This is mainly involved in promoting blood coagulation.

Conclusion

Thus, the coagulation modifiers are responsible for promoting or preventing the formation of blood clots.

Want to see more full solutions like this?

Subscribe now to access step-by-step solutions to millions of textbook problems written by subject matter experts!

Students have asked these similar questions

Question 1: You are the Community Dietitian for the local public health agency. Recent news coverage has highlighted the state of food insecurity and child hunger in your county. Initial reports indicate that 15% of the population is food insecure. Of this group, 28.4% are children. It is estimated that 86% of the food insecure population is eligible for federal nutrition assistance. You are asked to conduct a community needs assessment and, ultimately, develop an appropriate intervention aimed at reducing hunger. First, however, you must submit a plan for the needs assessment. Complete the following: 1. State the nutritional problem (10 pts) 2. Set the parameters of the assessment (20 pts, 5 pts per bullet) A. State the purpose of the assessment B. Identify the community and target population for this assessment C. Develop 2 goals and 2 SMART objectives for each goal D. Discuss the major categories of community data and target population data E. Specify the types of data you might…

Assignment Instructions: Nursing Research Essay Objective: Select a specific area of nursing that captivates your interest. Compose a comprehensive essay, ranging from 300 to 500 words, that delves into the intricacies of nursing research within your chosen area. It is recommended that you consider the topic carefully as this topic, should be the topic for your course research project: see week 4 assignments. Your essay should elucidate the following points: The Significance of Nursing Research: Explore how nursing research in your selected area contributes to advancements in applied medicine. Discuss the potential achievements and innovations that can arise from dedicated nursing research in this field. Articulate the value and impact of such research on patient care, healthcare practices, and overall medical knowledge. Research Methods and Approaches: Identify the most effective methods for conducting nursing research in your chosen area. Highlight specific topics or research…

The importance of understanding low meal consumption of residents in a nursing home and how can a nutritionist utilize this in their career? Please not just a short explanation.

Answer 2

Question

Chapter 26, Problem 1O

Summary Introduction

To Compare:

The coagulation process and the impact of coagulation modifier include anticoagulants, antiplatelet, thrombolytic, and antifibrinolytics.

Concept introduction:

Coagulation is otherwise called clotting. In this clotting process, the blood changes to gel from liquid. The forming of blood clot results in hemostasis. Generally, the clotting of blood occurs when the blood vessels are damaged. The protein is the coagulation process that is numbered by the Roman numerals from I- XIII. Some of the coagulation factors are II, VII, IX, and X, where all are produced in the liver except VIII.

Expert Solution & Answer

Explanation of Solution

Impact of coagulation modifier:

The coagulation modifier is the drug that takes action on the blood coagulation pathway to prevent or develop the formation of a clot. The coagulation modifiers are anticoagulants, antiplatelet drug, and thrombolytic drug.

Anticoagulants:

The anticoagulants prevent the formation of clotting factors and also avoid the formation of clots. The action of anticoagulant varying from one drug to another drug and the anticoagulant therapy are used for treating thrombosis.

Antiplatelet:

The antiplatelet blocks the platelet plugs from forming and preventing platelet aggregations. This process can be helpful in avoiding heart attack and strokes. Some of the antiplatelets include clopidogrel, dipyridamole, and ticlopidine.

Thrombolytic drug:

The important difference between thrombolytic and anticoagulant is to prevent the formation of blood clots. The thrombolytic drugs break the clots that are already present in the vessels. The thrombolytic is used as the injection to bust the clots by an intravenous line.

Antifibrinolytics drugs:

The hemostatic drug is otherwise called the antifibrinolytics drug that possesses the opposite effect when compared to the other class of drugs. This is mainly involved in promoting blood coagulation.

Conclusion

Thus, the coagulation modifiers are responsible for promoting or preventing the formation of blood clots.

Want to see more full solutions like this?

Subscribe now to access step-by-step solutions to millions of textbook problems written by subject matter experts!

Answer 3

Question

Chapter 26, Problem 1O

Summary Introduction

To Compare:

The coagulation process and the impact of coagulation modifier include anticoagulants, antiplatelet, thrombolytic, and antifibrinolytics.

Concept introduction:

Coagulation is otherwise called clotting. In this clotting process, the blood changes to gel from liquid. The forming of blood clot results in hemostasis. Generally, the clotting of blood occurs when the blood vessels are damaged. The protein is the coagulation process that is numbered by the Roman numerals from I- XIII. Some of the coagulation factors are II, VII, IX, and X, where all are produced in the liver except VIII.

Expert Solution & Answer

Explanation of Solution

Impact of coagulation modifier:

The coagulation modifier is the drug that takes action on the blood coagulation pathway to prevent or develop the formation of a clot. The coagulation modifiers are anticoagulants, antiplatelet drug, and thrombolytic drug.

Anticoagulants:

The anticoagulants prevent the formation of clotting factors and also avoid the formation of clots. The action of anticoagulant varying from one drug to another drug and the anticoagulant therapy are used for treating thrombosis.

Antiplatelet:

The antiplatelet blocks the platelet plugs from forming and preventing platelet aggregations. This process can be helpful in avoiding heart attack and strokes. Some of the antiplatelets include clopidogrel, dipyridamole, and ticlopidine.

Thrombolytic drug:

The important difference between thrombolytic and anticoagulant is to prevent the formation of blood clots. The thrombolytic drugs break the clots that are already present in the vessels. The thrombolytic is used as the injection to bust the clots by an intravenous line.

Antifibrinolytics drugs:

The hemostatic drug is otherwise called the antifibrinolytics drug that possesses the opposite effect when compared to the other class of drugs. This is mainly involved in promoting blood coagulation.

Conclusion

Thus, the coagulation modifiers are responsible for promoting or preventing the formation of blood clots.

Want to see more full solutions like this?

Subscribe now to access step-by-step solutions to millions of textbook problems written by subject matter experts!

Answer 4

Question

Chapter 26, Problem 1O

Summary Introduction

To Compare:

The coagulation process and the impact of coagulation modifier include anticoagulants, antiplatelet, thrombolytic, and antifibrinolytics.

Concept introduction:

Coagulation is otherwise called clotting. In this clotting process, the blood changes to gel from liquid. The forming of blood clot results in hemostasis. Generally, the clotting of blood occurs when the blood vessels are damaged. The protein is the coagulation process that is numbered by the Roman numerals from I- XIII. Some of the coagulation factors are II, VII, IX, and X, where all are produced in the liver except VIII.

Expert Solution & Answer

Explanation of Solution

Impact of coagulation modifier:

The coagulation modifier is the drug that takes action on the blood coagulation pathway to prevent or develop the formation of a clot. The coagulation modifiers are anticoagulants, antiplatelet drug, and thrombolytic drug.

Anticoagulants:

The anticoagulants prevent the formation of clotting factors and also avoid the formation of clots. The action of anticoagulant varying from one drug to another drug and the anticoagulant therapy are used for treating thrombosis.

Antiplatelet:

The antiplatelet blocks the platelet plugs from forming and preventing platelet aggregations. This process can be helpful in avoiding heart attack and strokes. Some of the antiplatelets include clopidogrel, dipyridamole, and ticlopidine.

Thrombolytic drug:

The important difference between thrombolytic and anticoagulant is to prevent the formation of blood clots. The thrombolytic drugs break the clots that are already present in the vessels. The thrombolytic is used as the injection to bust the clots by an intravenous line.

Antifibrinolytics drugs:

The hemostatic drug is otherwise called the antifibrinolytics drug that possesses the opposite effect when compared to the other class of drugs. This is mainly involved in promoting blood coagulation.

Conclusion

Thus, the coagulation modifiers are responsible for promoting or preventing the formation of blood clots.

Want to see more full solutions like this?

Subscribe now to access step-by-step solutions to millions of textbook problems written by subject matter experts!

Answer 5

Chapter 26, Problem 1O

Summary Introduction

To Compare:

The coagulation process and the impact of coagulation modifier include anticoagulants, antiplatelet, thrombolytic, and antifibrinolytics.

Concept introduction:

Coagulation is otherwise called clotting. In this clotting process, the blood changes to gel from liquid. The forming of blood clot results in hemostasis. Generally, the clotting of blood occurs when the blood vessels are damaged. The protein is the coagulation process that is numbered by the Roman numerals from I- XIII. Some of the coagulation factors are II, VII, IX, and X, where all are produced in the liver except VIII.

Expert Solution & Answer

Explanation of Solution

Impact of coagulation modifier:

The coagulation modifier is the drug that takes action on the blood coagulation pathway to prevent or develop the formation of a clot. The coagulation modifiers are anticoagulants, antiplatelet drug, and thrombolytic drug.

Anticoagulants:

The anticoagulants prevent the formation of clotting factors and also avoid the formation of clots. The action of anticoagulant varying from one drug to another drug and the anticoagulant therapy are used for treating thrombosis.

Antiplatelet:

The antiplatelet blocks the platelet plugs from forming and preventing platelet aggregations. This process can be helpful in avoiding heart attack and strokes. Some of the antiplatelets include clopidogrel, dipyridamole, and ticlopidine.

Thrombolytic drug:

The important difference between thrombolytic and anticoagulant is to prevent the formation of blood clots. The thrombolytic drugs break the clots that are already present in the vessels. The thrombolytic is used as the injection to bust the clots by an intravenous line.

Antifibrinolytics drugs:

The hemostatic drug is otherwise called the antifibrinolytics drug that possesses the opposite effect when compared to the other class of drugs. This is mainly involved in promoting blood coagulation.

Conclusion

Thus, the coagulation modifiers are responsible for promoting or preventing the formation of blood clots.

Answer 6

Chapter 26, Problem 1O

Summary Introduction

To Compare:

The coagulation process and the impact of coagulation modifier include anticoagulants, antiplatelet, thrombolytic, and antifibrinolytics.

Concept introduction:

Coagulation is otherwise called clotting. In this clotting process, the blood changes to gel from liquid. The forming of blood clot results in hemostasis. Generally, the clotting of blood occurs when the blood vessels are damaged. The protein is the coagulation process that is numbered by the Roman numerals from I- XIII. Some of the coagulation factors are II, VII, IX, and X, where all are produced in the liver except VIII.

Expert Solution & Answer

Explanation of Solution

Impact of coagulation modifier:

The coagulation modifier is the drug that takes action on the blood coagulation pathway to prevent or develop the formation of a clot. The coagulation modifiers are anticoagulants, antiplatelet drug, and thrombolytic drug.

Anticoagulants:

The anticoagulants prevent the formation of clotting factors and also avoid the formation of clots. The action of anticoagulant varying from one drug to another drug and the anticoagulant therapy are used for treating thrombosis.

Antiplatelet:

The antiplatelet blocks the platelet plugs from forming and preventing platelet aggregations. This process can be helpful in avoiding heart attack and strokes. Some of the antiplatelets include clopidogrel, dipyridamole, and ticlopidine.

Thrombolytic drug:

The important difference between thrombolytic and anticoagulant is to prevent the formation of blood clots. The thrombolytic drugs break the clots that are already present in the vessels. The thrombolytic is used as the injection to bust the clots by an intravenous line.

Antifibrinolytics drugs:

The hemostatic drug is otherwise called the antifibrinolytics drug that possesses the opposite effect when compared to the other class of drugs. This is mainly involved in promoting blood coagulation.

Conclusion

Thus, the coagulation modifiers are responsible for promoting or preventing the formation of blood clots.

Answer 7

Chapter 26, Problem 1O

Summary Introduction

To Compare:

The coagulation process and the impact of coagulation modifier include anticoagulants, antiplatelet, thrombolytic, and antifibrinolytics.

Concept introduction:

Coagulation is otherwise called clotting. In this clotting process, the blood changes to gel from liquid. The forming of blood clot results in hemostasis. Generally, the clotting of blood occurs when the blood vessels are damaged. The protein is the coagulation process that is numbered by the Roman numerals from I- XIII. Some of the coagulation factors are II, VII, IX, and X, where all are produced in the liver except VIII.

Answer 8

Expert Solution & Answer

Explanation of Solution

Impact of coagulation modifier:

The coagulation modifier is the drug that takes action on the blood coagulation pathway to prevent or develop the formation of a clot. The coagulation modifiers are anticoagulants, antiplatelet drug, and thrombolytic drug.

Anticoagulants:

The anticoagulants prevent the formation of clotting factors and also avoid the formation of clots. The action of anticoagulant varying from one drug to another drug and the anticoagulant therapy are used for treating thrombosis.

Antiplatelet:

The antiplatelet blocks the platelet plugs from forming and preventing platelet aggregations. This process can be helpful in avoiding heart attack and strokes. Some of the antiplatelets include clopidogrel, dipyridamole, and ticlopidine.

Thrombolytic drug:

The important difference between thrombolytic and anticoagulant is to prevent the formation of blood clots. The thrombolytic drugs break the clots that are already present in the vessels. The thrombolytic is used as the injection to bust the clots by an intravenous line.

Antifibrinolytics drugs:

The hemostatic drug is otherwise called the antifibrinolytics drug that possesses the opposite effect when compared to the other class of drugs. This is mainly involved in promoting blood coagulation.